Asan Medical Center: Stomach Neoplasms trials
The registry lists 31 Stomach Neoplasms studies with Asan Medical Center as lead sponsor. 5 are open to participants now and 7 have results posted.
Phase 1 9Phase 2 18Phase 3 6Phase 4 2No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Lenvatinib in Combination With Nivolumab Plus Chemotherapy in Metastatic Gastric Cancer Patients With Malignant AscitesRecruitingNCT07149090Phase 1/2
- A Phase Ib/II Trial of Neoadjuvant Zolbetuximab Plus Docetaxel, Oxaliplatin and S-1 Chemotherapy in Patients With Locally Advanced Gastric CancerRecruitingNCT06732856Phase 1/2
- A Phase 2 Study of Neoadjuvant Docetaxel, Oxaliplatin, S-1 in Patients With Unresectable Locally Advanced or Distant Metastasis Limited to Lymph Node Gastric CancerRecruitingNCT05184803Phase 2
- Compare Adjuvant Chemotherapy of Docetaxel/Capecitabine/Oxliplatin Versus Capecitabine/Oxaliplatin in Advanced Gastric Cancer at Stage IIIb and IV(KCSG ST15-08): TRIUMPHRecruitingNCT01935778Phase 3
- Adjuvant Capecitabine Versus Observation Alone in Curatively Resected Stage IB Gastric Cancer((KCSG ST14-05): CATALYSISRecruitingNCT01917552Phase 3
- RAD001 (Everolimus) Salvage Monotherapy in Advanced Gastric Cancer (AGC) Who Failed Standard First-line TreatmentCompletedNCT00729482Phase 2Results posted
- Capecitabine and Cisplatin (XP)+Sorafenib in Advanced Gastric Cancer (AGC): Sorafenib+XPCompletedNCT00565370Phase 1/2Results posted
- Study of Docetaxel, Capecitabine and Oxaliplatin in Advanced Stomach CancerCompletedNCT00446290Phase 1Results posted
- Study of XELOX With Cetuximab in Advanced Gastric CancerCompletedNCT00398398Phase 2Results posted
- Trial of Adjuvant Chemotherapy for Gastric CancerCompletedNCT00296335Phase 3Results posted
- Trial of Adjuvant Chemotherapy for Gastric CancerCompletedNCT00296322Phase 3Results posted
- Capecitabine Versus S-1 in Elderly Advanced Gastric Cancer (AGC): Randomized TrialCompletedNCT00278863Phase 2Results posted
- Robotic vs Laparoscopic and Open Surgery for Abdominopelvic CancersCompletedNCT07821775
- GC 2nd Line Durvalumab(MEDI4736)/Tremelimumab Plus Paclitaxel StudyCompletedNCT03751761Phase 1/2
- A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous ThromboembolismStatus unknownNCT03139487Phase 2
- Study of Gastroduodenal Metallic Stent vs GastrojejunostomyStatus unknownNCT02784470Phase 3
- Serum Cholesterol and Gastric NeoplasmStatus unknownNCT02041312
- Dovitinib Plus Docetaxel in Gastric CancerCompletedNCT01921673Phase 1/2
- Dovitinib for Gastric Cancer With FGFR2 Amplification: GASDOVI-1CompletedNCT01719549Phase 2
- Does Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial Ulcer After EMR or ESD?Status unknownNCT01621451Phase 4
- Safety Study of Combined Systemic and Intraperitoneal Chemotherapy to Treat Stomach CancerCompletedNCT01525771Phase 1/2
- RAD001 in Advanced Gastric Cancer Who Failed Standard First-line Treatment With pS6 Ser 240/4 ExpressionCompletedNCT01482299Phase 2
- Trastuzumab in Combination With Capecitabine and Oxaliplatin(XELOX) in Patients With Advanced Gastric Cancer(AGC): Her+XELOXCompletedNCT01396707Phase 2
- Investigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean PatientsStatus unknownNCT01271582Phase 4
- Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment Evaluation: STARGATECompletedNCT01187212Phase 2
- RAD001 in Combination With Capecitabine and Oxaliplatin (XELOX) in Patients With Advanced Gastric Cancer: RAD001+XELOXCompletedNCT01049620Phase 1
- Venous Thromboembolism in Advanced Gastric Cancer PatientsCompletedNCT01047618
- Study of Vorinostat Plus Capecitabine (X) and Cisplatin (P) for 1st Line Treatment of Metastatic or Recurrent Gastric Cancer: Zolinza+XPCompletedNCT01045538Phase 1/2
- Adjuvant Chemotherapy With Docetaxel, Capecitabine and Cisplatin in Patients With Advanced Gastric Cancer: Adjuvant DXPCompletedNCT00976976Phase 2
- Biweekly FOLFIRI in Advanced Gastric Cancer (AGC) With Failure of Prior Taxane, Fluoropyrimidine, and CisplatinCompletedNCT00976768Phase 2
- Trial of 3-weekly Versus 5-weekly Schedule of S-1 Plus Cisplatin in Gastric Cancer: SOSCompletedNCT00915382Phase 3